metformin has been researched along with megestrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aminimoghaddam, S; Fazaeli, M; Kashanian, M; Sharifzadeh, F; Sheikhansari, N | 1 |
| Cao, C; Gong, YJ; Guo, XJ; Li, GT; Li, Z; Shao, HH; Xie, SW; Yang, WJ; Zhong, RH; Zhou, JY; Zhu, Y | 1 |
1 review(s) available for metformin and megestrol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for metformin and megestrol
| Article | Year |
|---|---|
A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol; Metformin; Middle Aged; Outcome Assessment, Health Care | 2017 |
1 other study(ies) available for metformin and megestrol
| Article | Year |
|---|---|
Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endometrial Neoplasms; Estrogen Receptor alpha; Eukaryotic Initiation Factor-4G; Female; Humans; Megestrol; Metformin; Mice, Nude; Norpregnadienes; Phosphorylation; Receptors, Progesterone; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |